Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients

scientific article published on 14 June 2013

Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/AID.2013.0035
P932PMC publication ID3749689
P698PubMed publication ID23701022

P50authorShyam KottililQ87755004
P2093author name stringMichael A Polis
Anita Kohli
Emily K Funk
Henry Masur
Amy Nelson
Bhavana Shivakumar
Laura Heytens
Michael Sneller
Richard Kwan
Ashton Shaffer
P2860cites workPeginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patientsQ28274666
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trialQ28298301
Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaquesQ28775900
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002Q29619974
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapyQ34445911
Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected personsQ34565853
HIV/hepatitis C coinfection natural history and disease progressionQ35801431
Pharmacokinetic properties of nucleoside/nucleotide reverse transcriptase inhibitorsQ35866777
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysisQ37265953
Antiretroviral medications: adverse effects on the kidneyQ37652306
HIV and viral hepatitis coinfections: advances and challengesQ38002790
Severity and correlates of liver disease in hepatitis C virus-infected injection drug usersQ39600856
Tenofovir nephrotoxicity: 2011 updateQ42254390
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infectionQ42989510
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials GroupQ43036483
Hepatitis C virus infection and coinfection with human immunodeficiency virus: challenges and advancements in managementQ43038823
Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapyQ43693273
Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practiceQ45285932
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populationsQ45423073
HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.Q45489050
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc GroupQ45747079
Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects.Q50576419
Ribavirin potentiates the efficacy and toxicity of 2',3'- dideoxyinosine in the murine acquired immunodeficiency syndrome model.Q50588689
Tenofovir disoproxil fumarateQ73401251
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectimmunologyQ101929
infectious diseaseQ18123741
virologyQ7215
ribavirinQ421862
Hepatitis C virusQ708693
P304page(s)1190-1194
P577publication date2013-06-14
P1433published inAIDS Research and Human RetrovirusesQ4651880
P1476titleShort communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients
P478volume29

Reverse relations

cites work (P2860)
Q41984358HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study
Q33988140Inteleukin-23 promotes interferon-α responsiveness in hepatitis C virus/HIV-coinfected patients
Q37062210Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin

Search more.